Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Appointment of Non-executive Director

16 Oct 2020 09:21

RNS Number : 3303C
InnovaDerma PLC
16 October 2020
 

 LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Group")

Appointment of Non-executive Director

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life science products, is pleased to announce that Mark Michael Ward has been appointed as Non-executive Director of the Group with effect from the 19 October 2020.

Mark is a successful and experienced digital and technology professional with strong links to the consumer and service industries. He founded Hunter Macdonald, a digital transformation and services company in 2013 and under his leadership, the business employed more than 400 employees within 5 years. In 2017, Hunter Macdonald was recognised as being one of the fastest growing companies in the UK and in October of the same year, the business merged with Scandinavian based Netcompany which is now publicly listed on Nasdaq OMX. Mark began his career at PwC working in M&A and operations and spent c.13 years in senior operational director roles for Reckitt Benckiser, Verizon, BT and Friends Life.

Corporate Governance Information 

As at the date of this announcement 1,786,590 ordinary shares of €0.10 each in the Group are held by Mark Michael Ward.

Under the provisions of the UK Corporate Governance Code, Mark will not be considered to be an independent Non-Executive Director.

 

Executive Chairman and Interim CEO, Joe Bayer, said:

"We are pleased to welcome Mark to the Board. Mark brings with him a wealth of technology and FMCG experience which achieves a key board objective of adding more diversity in digital and marketing expertise to the Company's existing strong, multi-disciplinary Board. We look forward to working with him as we continue to implement our strategy and deliver further successes."

 

Mark Michael Ward said:

"I am very excited to join InnovaDerma. I have always had a passion for consumer centric businesses and relish the opportunity to work for InnovaDerma which marries high quality brands and a growing digital platform and distribution network. The business has significant opportunities globally and I look forward to working alongside the team to further grow the business."

 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Mark Michael Ward's appointment.

 

 

Further enquiries

 

InnovaDerma

Joe Bayer

 

 

+61 417 870 743

 

finnCap Ltd

Geoff Nash/Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking

 

+44 (0)207 220 0500

www.finncap.com

TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser

 

+ 44 (0)20 7930 0777

innovaDerma@tbcardew.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAKKABBFBDKKKD

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.